Net Cash Provided by (Used in) Operating Activities |
-54K |
USD |
-92% |
Q4 2022 |
Q1 2023 |
Net Cash Provided by (Used in) Financing Activities |
59.6K |
USD |
+112% |
Q4 2022 |
Q1 2023 |
Common Stock, Shares Authorized |
750M |
shares |
0% |
Q2 2023 |
Q3 2023 |
Common Stock, Shares, Issued |
63.6M |
shares |
+85969% |
Q2 2023 |
Q3 2023 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2023 |
Q3 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
5.62K |
USD |
|
Q4 2022 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
2.95K |
USD |
+2262% |
Q2 2023 |
Q3 2023 |
Deferred Tax Assets, Valuation Allowance |
429K |
USD |
+130% |
Q1 2023 |
Q2 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q4 2022 |
Q1 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
2.07M |
USD |
+134% |
Q1 2023 |
Q2 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2023 |
Q3 2023 |
Preferred Stock, Shares Authorized |
125M |
shares |
|
Q2 2023 |
Q3 2023 |
Additional Paid in Capital |
1.81M |
USD |
+36.6% |
Q2 2023 |
Q3 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2023 |
Q3 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
429K |
USD |
+130% |
Q1 2023 |
Q2 2023 |
Interest Expense |
5K |
USD |
|
Q1 2023 |
Q2 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2023 |
Q3 2023 |